Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma.
Front Oncol. 2023 Feb 3;13:1082771. doi: 10.3389/fonc.2023.1082771. eCollection 2023.
Front Oncol. 2023.
PMID: 36816982
Free PMC article.
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.
Lode HN, Ladenstein R, Troschke-Meurer S, Struppe L, Siebert N, Zumpe M, Ehlert K, Huber S, Glogova E, Hundsdoerfer P, Eggert A, Zaniewska-Tekieli A, Balwierz W, Wieczorek A.
Lode HN, et al. Among authors: zaniewska tekieli a.
Cancers (Basel). 2023 Jun 27;15(13):3364. doi: 10.3390/cancers15133364.
Cancers (Basel). 2023.
PMID: 37444475
Free PMC article.
Item in Clipboard
Cite
Cite